GlassScriptPhysician profile
Georgia Harper
NPI 1285100446
$4,331.24
in general payments reported to CMS, 2019-2025
24 companies · $2,004 in 2025
The $2,004 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $248 · 2022: $799 · 2023: $878 · 2024: $402 · 2025: $2,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,919 · Travel and Lodging: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,918.60 |
| Travel and Lodging | $365.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,688.52 | 2021-2025 | Synchromedii, Inceptiv, Accurian |
| Saluda Medical Americas, INC. | $500.06 | 2025 | Evoke |
| Nevro Corp. | $402.72 | 2021-2024 | Senza |
| Abbvie INC. | $358.28 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $284.61 | 2022-2024 | Relistor |
| Relievant Medsystems, INC. | $197.61 | 2023 | Intracept |
| Vertos Medical, INC. | $187.46 | 2023-2024 | Mild Device Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $147.04 | 2022 | |
| Boston Scientific Corporation | $118.53 | 2022-2024 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Stryker Corporation | $73.26 | 2025 | Optablate |
| Pfizer INC. | $71.22 | 2023-2024 | |
| Averitas Pharma INC. | $40.55 | 2024 | Qutenza |
| Amgen INC. | $35.12 | 2022 | |
| Curonix LLC | $32.14 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $31.45 | 2023-2024 | Belbuca, Xtampza |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $29.54 | 2021 | |
| Azurity Pharmaceuticals, INC. | $20.65 | 2023 | Horizant |
| Painteq LLC | $19.54 | 2024 | Painteq |
| Arbor Pharmaceuticals, INC. | $18.53 | 2022 | |
| Lundbeck LLC | $16.49 | 2022 | |
| Grt US Holding, INC. | $16.43 | 2022 | |
| Lilly USA, LLC | $16.33 | 2021 | |
| Mml US, INC. | $12.85 | 2025 | Reactiv8 |
| Merck Sharp & Dohme LLC | $12.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Georgia Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.